Clinical Study

Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion

Table 3

The mean central retinal thickness values and the change in central retinal thickness in the study groups at different time points.

IVT + GLPIVB + GLP value*

Baseline CRT (microns) 0.3

Month 3 CRT (Microns) 0.3
Mean change from baseline (Microns)
Baseline vs month 3 valueP < 0.0001 P < 0.0001

Month 6 CRT (Microns) 0.4
Mean change from baseline (Microns)
Baseline vs month 6 valueP < 0.0001 P < 0.0001

Month 9 CRT 0.9
Mean change from baseline (Microns)
Baseline vs month 9 valueP < 0.0001 P < 0.0001

Month 12 CRT (Microns) 0.9
Mean change from baseline (Microns)
Baseline vs month 12 valueP < 0.0001 P < 0.0001

Month 15 CRT (Microns) 0.7
Mean change from baseline (Microns)
Baseline vs month 15 valueP < 0.0001 P < 0.0001

Month 18 CRT (Microns) 0.8
Mean change from baseline (Microns)
Baseline vs month 18 valueP < 0.0001 P < 0.0001

Month 21 CRT (Microns) 0.9
Mean change from baseline (Microns)
Baseline vs month 21 valueP < 0.0001 P < 0.0001

Month 24 CRT (Microns) 0.9
Mean change from baseline (Microns)
Baseline vs month 24 valueP < 0.0001 P < 0.0001

for baseline CRT, values for IVT versus IVB are for the baseline values themselves; the other values are for the change achieved with the two drugs relative to the baseline values. CRT: central retinal thickness; vs: versus; IVT: intravitreal triamcinolone; GLP: grid laser photocoagulation; IVB: intravitreal bevacizumab; P value less than 0.05 was considered statistically significant.